List of insiders holdings for ENZON PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| COUCHMAN JONATHAN Couchman Family Fund Xstelos Corp. Myrexis Inc. Harper Brian James HARPER ASSET MANAGEMENT LLC Pearce Michael Cooper 10% Owner | 2020-09-17 16:12:32 | 7,851,454 0 | 7,851,454 | Form 13D |
| COUCHMAN JONATHAN Couchman Family Fund Xstelos Corp. Myrexis Inc. 10% Owner | 2021-08-17 18:07:15 | 0 7,393,954 | 7,393,954 | Form 4 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC HIGHBRIDGE CAPITAL CORP Highbridge International LLC Dubin Glenn Swieca Henry 10% Owner | 2012-02-14 11:11:39 | 2,293,193 0 | 2,293,193 | Form 13G |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC Highbridge International LLC Dubin Glenn Swieca Henry Highbridge Convertible Arbitrage Master Fund L.P. 10% Owner | 2012-02-14 11:11:39 | 2,293,193 0 | 2,293,193 | Form 13G |
| BUCHALTER JEFFREY H CEO & President | 2010-01-29 16:59:26 | 529,259 0 | 529,259 | Form 4 |
| TOOMAN CRAIG A Exec VP Finance, CFO | 2010-06-22 17:02:34 | 319,680 0 | 319,680 | Form 4 |
| HIGGINS ARTHUR J Director | 2004-07-14 15:49:14 | 240,072 0 | 240,072 | Form 4/A |
| del Campo Ralph COO and Princ. Exec. Officer | 2011-09-19 19:22:17 | 204,633 0 | 204,633 | Form 4 |
| READ RANDOLPH C Director | 2023-06-16 16:05:38 | 200,000 0 | 200,000 | Form 4 |
| Levy Harold J Director | 2010-03-10 13:38:19 | 0 166,535 | 166,535 | Form 4 |
| HORAK IVAN D EVP, R&D, CSO | 2011-04-05 17:04:23 | 138,476 0 | 138,476 | Form 4 |
| Stancic Ana Executive VP, COO, PEO CFO | 2012-01-19 18:48:23 | 125,000 0 | 125,000 | Form 4/A |
| HEBARD GEORGE Interim PEO and Interim COO | 2012-11-08 15:47:30 | 116,737 0 | 116,737 | Form 4 |
| Davit Paul Stephen Exec. Vice Pres. HR | 2011-07-06 12:28:00 | 109,314 0 | 109,314 | Form 4 |
| Bleznick Jordan Director | 2020-11-17 18:11:27 | 100,000 0 | 100,000 | Form 4 |
| Buchbinder Aby VP, Clinical Development | 2013-01-25 18:14:59 | 79,246 0 | 79,246 | Form 4 |
| Conover Charles SVP, R&D Program Management | 2013-01-25 18:11:23 | 74,793 0 | 74,793 | Form 4 |
| ZUERBLIS KENNETH J Executive V.P., Finance, CFO | 2004-06-15 17:32:56 | 60,330 0 | 60,330 | Form 4 |
| MICATI VICTOR P Director | 2010-07-06 19:00:16 | 50,625 0 | 50,625 | Form 4 |
| GRAU ULRICH M Chief Scientific Officer | 2004-04-05 17:34:57 | 50,000 0 | 50,000 | Form 4 |
| Greenberger Lee M VP, Research | 2012-01-19 18:45:13 | 48,146 0 | 48,146 | Form 4 |
| ANDO GORAN Director | 2009-07-06 16:52:23 | 43,582 0 | 43,582 | Form 4 |
| GOLDE DAVID Director | 2004-07-06 19:51:57 | 3268 39,100 | 42,368 | Form 4 |
| LEBUHN ROBERT Director | 2013-09-19 18:12:57 | 42,189 0 | 42,189 | Form 4 |
| DENNER ALEXANDER J Director | 2013-01-04 11:24:39 | 40,258 0 | 40,258 | Form 4 |
| ICAHN CARL C 10% Owner | 2020-10-14 17:00:39 | 0 39,277 | 39,277 | Form 4 |
| Mulligan Richard Director | 2013-01-04 11:26:30 | 35,226 0 | 35,226 | Form 4 |
| Renfro Phillip M Director | 2009-01-06 15:08:00 | 33,453 0 | 33,453 | Form 4 |
| Geltosky John Director | 2009-01-06 15:07:59 | 33,453 0 | 33,453 | Form 4 |
| Rackear Andrew D. CEO and Secretary | 2016-04-05 16:15:22 | 25,000 0 | 25,000 | Form 3 |
| SALISBURY ROBERT C Director | 2013-01-04 11:27:20 | 20,129 0 | 20,129 | Form 4 |
| Deuel Thomas Director | 2013-01-04 11:33:54 | 20,129 0 | 20,129 | Form 4 |
| Young Richard A Director | 2013-01-04 11:34:57 | 20,129 0 | 20,129 | Form 4 |
| CLASSON ROLF A Director | 2011-01-05 16:16:47 | 16,996 0 | 16,996 | Form 4 |
| DIXON ROSINA B Director | 2006-01-04 17:00:09 | 15,000 0 | 15,000 | Form 4 |
| Daly Timothy VP, Controller and PAO | 2012-03-29 15:40:18 | 8000 0 | 8000 | Form 4 |
| PARKINSON ROBERT L JR Director | 2004-04-01 17:24:56 | 6738 0 | 6738 | Form 4 |
| Ogden Mark L Acting VP of Fin & Prin FO | 2011-03-01 16:10:02 | 4000 0 | 4000 | Form 4 |
| BARLOW DAVID S Director | 2004-01-05 15:31:49 | 209 0 | 209 | Form 4 |
| FEINSTEIN RICHARD L VP-Finance and PFO | 2013-12-13 18:06:43 | 0 0 | 0 | Form 3 |
| CHRISTODORO JONATHAN Director | 2013-10-09 16:40:00 | 0 0 | 0 | Form 3 |
| McNealey Jennifer Isacoff Director | 2013-10-07 19:15:55 | 0 0 | 0 | Form 3 |
| Kostas Odysseas D Director | 2013-10-07 19:14:17 | 0 0 | 0 | Form 3 |
| IRIDIAN ASSET MANAGEMENT LLC 10% Owner | 2013-01-31 09:11:42 | 0 0 | 0 | Form 13G |
| Firestone Jaffrey Adam Director | 2022-06-21 16:31:00 | 0 0 | 0 | Form 3 |